TipRanks

Richard Peters Insider Profile

11 Followers
Richard Peters, Director at Aprea Therapeutics, holds 6.25K shares in Aprea Therapeutics (Ticker: APRE), holds 0.00 shares in Kineta (Ticker: KANT), holds ― shares in Merrimack Pharmaceuticals (Ticker: MACK).
tipranks
Richard Peters

Richard Peters
Aprea Therapeutics (APRE)
Director

Ranked #45,330 out of 109,193 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+5.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5K
100.00%
A breakdown of Richard Peters's holdings

Insider Roles

Aprea Therapeutics
(APRE)
Director
Roles that Richard Peters holds in companies

Most Profitable Insider Trade

Stock:
Kineta
(KANT)
Rating:Informative Sell
Date:Jul 06, 2022 - Jul 06, 2023
Return:+24.60%
The most profitable trade made by Richard Peters

Richard Peters's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aprea Therapeutics
Jun 17, 2026
Director
Uninformative Buy
―
$4.69K
KANT
Kineta
Jul 02, 2025
―
Uninformative Sell
―
$0.00
MACK
Merrimack Pharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see Richard Peters's performance on stock

Richard Peters insider profile FAQ

What is the percentage of profitable transactions made by Richard Peters?
The percentage of profitable transactions made by Richard Peters is 67%.
    What is the average return per transaction made by Richard Peters?
    The average return per transaction made by Richard Peters is 5.00%.
      What stocks does Richard Peters hold?
      Richard Peters holds: APRE, KANT, MACK stocks.
        What was Richard Peters’s latest transaction?
        Richard Peters latest transaction was an Uninformative Buy of ―.
          What was Richard Peters's most profitable transaction?
          Richard Peters’s most profitable transaction was an Informative Sell of KANT stock on July 6, 2022. The return on the trade was 24.60%.
            What is Richard Peters's role in Aprea Therapeutics?
            Richard Peters's role in Aprea Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.